Analyst Consensus ?
ConsensusHold42 ratings
Bullish1740.5%
Neutral2252.4%
Bearish37.1%
FN2 Earnings Intelligence
Zimmer Biomet Holdings, Inc. analyst ratings
Zimmer Biomet Holdings, Inc. (ZBH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$96.39Previous close
$83Low
$118.98Average
$180High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Buy | Buy | Maintain | Oct 22, 2026 |
| Canaccord Genuity | Hold | Hold | Maintain | Aug 10, 2026 |
| Truist Securities | Hold | Hold | Maintain | Aug 7, 2026 |
| Stifel | Buy | Buy | Maintain | Aug 6, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 6, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Aug 6, 2026 |
| BMO Capital | Market Perform | Outperform | Downgrade | Jul 9, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 28, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Apr 29, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Apr 29, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Apr 29, 2026 |
| Barclays | Underweight | Underweight | Maintain | Apr 29, 2026 |
| BTIG | Neutral | Buy | Downgrade | Mar 23, 2026 |
| Needham | Hold | Hold | Maintain | Feb 10, 2026 |
| UBS | Sell | Sell | Maintain | Jan 28, 2026 |
| Baird | Neutral | Outperform | Downgrade | Dec 16, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Aug 8, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | May 7, 2025 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 6, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | May 6, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Oct 15, 2024 |
| TD Cowen | Hold | Hold | Maintain | Sep 6, 2024 |
| Piper Sandler | Neutral | Overweight | Downgrade | Jul 1, 2024 |
| B of A Securities | Neutral | Underperform | Upgrade | May 3, 2023 |
| Jefferies | Hold | Underperform | Upgrade | Mar 31, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | May 4, 2022 |
| Loop Capital | Hold | Buy | Downgrade | Mar 2, 2022 |
| Deutsche Bank | Hold | Hold | Maintain | Feb 8, 2022 |
| Northland Capital Markets | Outperform | Market Perform | Upgrade | Apr 9, 2021 |
| Credit Suisse | Underperform | Underperform | Maintain | Nov 9, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 12, 2020 |
| Guggenheim | Neutral | Buy | Downgrade | Apr 28, 2020 |
| Argus | Buy | Hold | Upgrade | Aug 12, 2019 |
| Citi | Buy | Buy | Maintain | Aug 2, 2019 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 30, 2018 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Jan 31, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Jan 31, 2018 |
| Edward Jones | Buy | Hold | Upgrade | Nov 9, 2017 |
| PiperJaffray | Neutral | Overweight | Downgrade | Nov 2, 2017 |
| Northcoast Research | Neutral | Buy | Downgrade | Nov 8, 2016 |
| Northland Securities | Perform | Outperform | Downgrade | Jan 7, 2016 |
Named analyst price targets
Upside is calculated against the persisted previous close $96.39. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Canaccord Genuity | Caitlin Cronin | $100 | $96.55 | +3.7% | Aug 10, 2026 |
| Truist Financial | Analyst unavailable | $106 | $96.62 | +10.0% | Aug 6, 2026 |
| Robert W. Baird | Analyst unavailable | $104 | $97.32 | +7.9% | Aug 6, 2026 |
| UBS | Patrick Wood | $120 | $97.06 | +24.5% | Aug 6, 2026 |
| Bernstein | Analyst unavailable | $93 | $97.53 | -3.5% | Aug 6, 2026 |
| BMO Capital | Analyst unavailable | $96 | $98.16 | -0.4% | Aug 6, 2026 |
| RBC Capital | Kendall Au | $110 | $98.16 | +14.1% | Aug 6, 2026 |
| UBS | Patrick Wood | $115 | $92.07 | +19.3% | Jul 28, 2026 |
| BMO Capital | Analyst unavailable | $95 | $87.56 | -1.4% | Jul 8, 2026 |
| Truist Financial | Analyst unavailable | $92 | $80.8 | -4.6% | Apr 29, 2026 |
| Canaccord Genuity | Analyst unavailable | $83 | $82.8 | -13.9% | Apr 29, 2026 |
| Stifel Nicolaus | Rick Wise | $105 | $82.8 | +8.9% | Apr 29, 2026 |
| Robert W. Baird | Analyst unavailable | $92 | $82.8 | -4.6% | Apr 29, 2026 |
| Barclays | Matt Miksic | $94 | $82.8 | -2.5% | Apr 29, 2026 |
| Barclays | Matt Miksic | $100 | $96.69 | +3.7% | Feb 12, 2026 |
| UBS | Analyst unavailable | $89 | $93.69 | -7.7% | Feb 11, 2026 |
| UBS | Analyst unavailable | $86 | $85.27 | -10.8% | Jan 28, 2026 |
| Bernstein | Analyst unavailable | $99 | $94.08 | +2.7% | Jan 9, 2026 |
| Goldman Sachs | David Roman | $93 | $94.08 | -3.5% | Jan 9, 2026 |
| Evercore ISI | Analyst unavailable | $120 | $90.02 | +24.5% | Jan 5, 2026 |
| Robert W. Baird | Jeff Johnson | $100 | $92.52 | +3.7% | Dec 16, 2025 |
| Stifel Nicolaus | Rick Wise | $110 | $87.91 | +14.1% | Nov 5, 2025 |
| Johnson Rice | Analyst unavailable | $112 | $88.05 | +16.2% | Nov 5, 2025 |
| Barclays | Analyst unavailable | $105 | $103.18 | +8.9% | Nov 5, 2025 |
| BTIG | Ryan Zimmerman | $122 | $94.71 | +26.6% | Oct 13, 2025 |
| RBC Capital | Analyst unavailable | $111 | $95.52 | +15.2% | Oct 10, 2025 |
| Stifel Nicolaus | Analyst unavailable | $118 | $100.36 | +22.4% | Sep 19, 2025 |
| Redburn Partners | Ed Ridley-Day | $130 | $100.21 | +34.9% | Sep 18, 2025 |
| UBS | Danielle Antalffy | $96 | $97.94 | -0.4% | Aug 8, 2025 |
| Truist Financial | Richard Newitter | $101 | $92.27 | +4.8% | May 6, 2025 |
| RBC Capital | Shagun Singh | $112 | $92.27 | +16.2% | May 6, 2025 |
| Stifel Nicolaus | Rick Wise | $115 | $90.48 | +19.3% | May 6, 2025 |
| Wells Fargo | Larry Biegelsen | $98 | $90.48 | +1.7% | May 5, 2025 |
| Truist Financial | Richard Newitter | $117 | $106.92 | +21.4% | Oct 31, 2024 |
| Oppenheimer | Steven Lichtman | $135 | $104.83 | +40.1% | Oct 15, 2024 |
| BTIG | Ryan Zimmerman | $126 | $105.69 | +30.7% | Oct 3, 2024 |
| Evercore ISI | Vijay Kumar | $110 | $107.95 | +14.1% | Oct 1, 2024 |
| Truist Financial | Richard Newitter | $112 | $105.14 | +16.2% | Sep 13, 2024 |
| Canaccord Genuity | Caitlin Cronin | $115 | $104.83 | +19.3% | Sep 10, 2024 |
| Raymond James | Jayson Bedford | $128 | $107.09 | +32.8% | Aug 8, 2024 |
| Oppenheimer | Steven Lichtman | $145 | $105.81 | +50.4% | Aug 8, 2024 |
| Stifel Nicolaus | Rick Wise | $130 | $107.5 | +34.9% | Aug 7, 2024 |
| Morgan Stanley | Drew Ranieri | $120 | $108.69 | +24.5% | Jul 15, 2024 |
| Piper Sandler | Matt O'Brien | $115 | $108.53 | +19.3% | Jul 1, 2024 |
| Piper Sandler | Matthew O\'Brien | $140 | $114.44 | +45.2% | May 31, 2024 |
| RBC Capital | Shagun Singh | $140 | $115.14 | +45.2% | May 30, 2024 |
| BTIG | Ryan Zimmerman | $139 | $116.41 | +44.2% | May 28, 2024 |
| Argus Research | David Toung | $150 | $119.05 | +55.6% | May 21, 2024 |
| Truist Financial | Analyst unavailable | $137 | $128.46 | +42.1% | Feb 6, 2023 |
| Morgan Stanley | Analyst unavailable | $140 | $128.82 | +45.2% | Feb 6, 2023 |
| RBC Capital | Analyst unavailable | $141 | $125.7 | +46.3% | Jan 9, 2023 |
| Morgan Stanley | Analyst unavailable | $135 | $126.77 | +40.1% | Jan 6, 2023 |
| Truist Financial | Analyst unavailable | $135 | $124.91 | +40.1% | Dec 20, 2022 |
| Citigroup | Analyst unavailable | $130 | $125.36 | +34.9% | Dec 12, 2022 |
| Wells Fargo | Larry Biegelsen | $124 | $115.33 | +28.6% | Nov 23, 2022 |
| Stifel Nicolaus | Analyst unavailable | $120 | $104.62 | +24.5% | Jul 18, 2022 |
| RBC Capital | Analyst unavailable | $128 | $122.2 | +32.8% | May 4, 2022 |
| Piper Sandler | Matt O'Brien | $130 | $121.37 | +34.9% | May 3, 2022 |
| Bank of America Securities | Travis Steed | $120 | $122.13 | +24.5% | Mar 3, 2022 |
| JMP Securities | David Turkaly | $145 | $116.08 | +50.4% | Feb 8, 2022 |
| RBC Capital | Shagun Singh Chadha | $125 | $116.08 | +29.7% | Feb 8, 2022 |
| Truist Financial | Samuel Brodovsky | $128 | $116.08 | +32.8% | Feb 8, 2022 |
| Canaccord Genuity | Kyle Rose | $125 | $108.13 | +29.7% | Feb 7, 2022 |
| Deutsche Bank | Pito Chickering | $121 | $108.13 | +25.5% | Feb 7, 2022 |
| Leerink Partners | Danielle Antalffy | $135 | $108.13 | +40.1% | Feb 7, 2022 |
| Piper Sandler | Matthew O'Brien | $110 | $108.13 | +14.1% | Feb 7, 2022 |
| Robert W. Baird | Jeff Johnson | $138 | $108.13 | +43.2% | Feb 7, 2022 |
| Needham | Michael Matson | $143 | $108.13 | +48.4% | Feb 7, 2022 |
| Cowen & Co. | Josh Jennings | $140 | $119.14 | +45.2% | Jan 20, 2022 |
| Motley Fool | Anders Bylund | $140 | $121.23 | +45.2% | Dec 9, 2021 |
| Jefferies | Anthony Petrone | $175 | $136.9 | +81.6% | Nov 5, 2021 |
| Guggenheim | Christopher Pasquale | $180 | $136.9 | +86.7% | Nov 5, 2021 |
| Evercore ISI | Vijay Kumar | $170 | $133.13 | +76.4% | Nov 4, 2021 |
| Oppenheimer | Steven Lichtman | $190 | $143.03 | +97.1% | Aug 4, 2021 |
Track every rating change on ZBH the moment it posts. Free to start.
Start freeGet the ZBH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.